Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
2024-04-15_CP_Brevet_OBA
By
admin
April 15, 2024
240408_PR_OBA_Program
By
admin
April 8, 2024
240408_CP_Programme_OBA
By
admin
April 8, 2024
240408_PR_2023_FY_Results
By
admin
April 8, 2024
240408_CP_Resultats_Annuels_2023
By
admin
April 8, 2024
2024_04_04_PR_AGM_results_EN
By
admin
April 4, 2024
2024_04_04_CP_CR_AGM_2_Avril_2024_FR
By
admin
April 4, 2024
240322_PR_ICFSR
By
admin
March 22, 2024
240322_CP_ICFSR
By
admin
March 22, 2024
240318_PR_CGM_2024
By
admin
March 18, 2024
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
…
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
